- Home
- Equipment
- canada alberta
- clinical development
Refine by
Clinical Development Equipment Supplied In Canada Alberta
5 equipment items found
Manufactured by:Aurinia Pharmaceuticals Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
BAFF and APRIL promote B cell survival and differentiation and have been shown to play a prominent role in the pathogenesis of certain autoimmune and nephrology conditions. AUR200 is currently undergoing pre-clinical development with projected submission of an IND to the FDA in ...
Manufactured by:Aurinia Pharmaceuticals Inc. based inVictoria, BRITISH COLUMBIA (CANADA)
Dysregulation of M2 macrophages drives fibrosis. AUR300 acts to reduce M2 dysregulation and decrease inflammatory cytokines, and therefore may have significant clinical applications for autoimmune and fibrotic diseases. It is anticipated that clinical development for AUR300 will commence during the first half of ...
Manufactured by:Biotest AG based inDreieich, GERMANY
Trimodulin mediates its mode of action via three potential mechanisms which are; opsonization of causal pathogens, neutralizing of microbial pathogens and their virulence factors (endo- and exotoxins) and targeting the host inflammatory response (anti-inflammatory properties). Currently, trimodulin is under clinical development for severe community-acquired ...
Manufactured by:Biotest AG based inDreieich, GERMANY
At the ISTH 2020 Biotest presented its novel recombinant Factor VIII molecules overcoming the major challenges of current Factor VIII replacement therapy by combining a significantly extended half-life, low immunogenicity and the possibility of either subcutaneous or intravenous ...
Manufactured by:Biotest AG based inDreieich, GERMANY
Trimodulin is an innovative polyvalent antibody composition, purified from human plasma. In comparison to standard IgG preparations (IVIG), trimodulin contains relevant amounts of IgM and IgA in addition to ...